Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1997-2-18
pubmed:abstractText
Salivary binding antibodies induced by candidate human immunodeficiency virus type 1 (HIV-1) vaccines in healthy, HIV-1 uninfected volunteers were assessed in a clinical trial evaluating intramuscularly injected HIV-1MN recombinant gp120 (rgp120) vaccine alone or with HIV-1IIIB rgp120 vaccine. The two rgp120 vaccines induced envelope glycoprotein-specific immunoglobulin G (IgG) and IgA antibodies in whole saliva and serum.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-1346285, http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-1466996, http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-1517967, http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-1539467, http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-1602554, http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-1609280, http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-1672924, http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-1845126, http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-2190095, http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-2204698, http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-3277513, http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-3531561, http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-7474077, http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-7625118, http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-7658082, http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-7751656, http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-7814455, http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-7913731, http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-7986587, http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-8028613, http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-8100910, http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-8157978, http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-8369168, http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-8441249, http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-8493576, http://linkedlifedata.com/resource/pubmed/commentcorrection/8914773-8678387
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1071-412X
pubmed:author
pubmed:issnType
Print
pubmed:volume
3
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
769-73
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1996
pubmed:articleTitle
Salivary binding antibodies induced by human immunodeficiency virus type 1 recombinant gp120 vaccine. The NIAID AIDS Vaccine Evaluation Group.
pubmed:affiliation
Department of Internal Medicine, Saint Louis University School of Medicine, Missouri, USA.
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Controlled Clinical Trial